COMMUNIQUÉS West-GlobeNewswire

TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results
24/03/2026
MALVERN, Pa., March 24, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial [...]
PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results
24/03/2026
PRINCETON, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets [...]
MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance
24/03/2026
Fourth quarter 2025 total revenue of $7.3 million at the top of the range of previous preliminary announcement Full year 2025 revenue of $33.0 million, at the top of the range of previous preliminary announcement Total [...]
DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
24/03/2026
Châtillon, France, March 24, 2026 DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review Changes went into effect on Monday, March 23, 2026 DBV Technologies (Euronext: DBV – ISIN [...]
BioSyent Announces Grant of Restricted Share Units
24/03/2026
MISSISSAUGA, Ontario, March 24, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent” or the “Company”, TSX Venture: RX) announces that its Board of Directors has approved a grant of 44,222 Restricted Share Units “RSUs” to [...]
Solana Company to Release Fourth Quarter and Full Year 2025 Operating Results on March 30, 2026
24/03/2026
NEWTOWN, Pa., March 24, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company that has expanded its business to include a digital asset treasury dedicated to [...]
Spectral AI Announces 2025 Fourth Quarter and Full Year Financial Results and Introduces Revenue Guidance for 2026
24/03/2026
Overview Full Year Research & Development Revenue of $19.7 Million; Q4 2025 Revenue of $3.8 Million Cash Rose to $15.4 Million at December 31, 2025 DALLAS, March 24, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. ( [...]
ATI Advisory Designs Medicare-Based Model to Support Needs of the “Overlooked Middle;” Actuarial Analysis Projects Over $500 Million in Savings
24/03/2026
Newly designed model concept demonstrates viable pathway to deliver targeted home- and community-based services within Traditional Medicare; projected to reduce Medicare spending Washington, DC, March 24, 2026 (GLOBE [...]
SK pharmteco et Prozomix annoncent une collaboration stratégique visant à renforcer leurs capacités en matière de biocatalyse pour la fabrication de médicaments à l’échelle mondiale
24/03/2026
RANCHO CORDOVA, Californie, 24 mars 2026 (GLOBE NEWSWIRE) -- SK pharmteco , une organisation mondiale de premier plan spécialisée dans le développement et la fabrication sous contrat (CDMO) et Prozomix , pionnière dans [...]
Tatwa Integrative Medicine Establishes Itself as Europe's Reference for Amazonian Floral Essences and Launches Its 10th Vibratory Elixir
24/03/2026
The Colombian-Swiss company Tatwa Integrative Medicine is cementing its leadership in the integrative medicine and wellness market with the launch of Tabaco, a floral essence for clarity, energetic protection and inner [...]
CROSSJECT publie ses résultats financiers 2025 et confirme le renforcement de sa trajectoire opérationnelle, industrielle et financière
24/03/2026
DIJON, France – 24 mars 2026 (18H30 CET) – CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), société pharmaceutique de spécialités qui développe des produits dédiés aux situations d’urgence fondés sur sa technologie [...]
Decisions taken by Orion Corporation's Annual General Meeting and Board of Directors' organising meeting on 24 March 2026
24/03/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – DECISIONS OF GENERAL MEETING 24 MARCH 2026 at 16.30 EET Decisions taken by Orion Corporation's Annual General Meeting and Board of Directors' organising meeting on 24 March [...]
Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation
24/03/2026
Press release – No. 6 / 2026 Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation New research hub in Cambridge, Massachusetts, [...]
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings
24/03/2026
Southlake, TX, March 24, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography [...]
Baylor Genetics Connects with Genetic Counselors to Advance Answers in Rare and Undiagnosed Disease
24/03/2026
HOUSTON, March 24, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics , a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced it will be [...]
Adjustment of guidance for 2025/26
24/03/2026
ANNOUNCEMENT NO. 303 24 March 2026 Adjustment of guidance for 2025/26 Over the past period, ChemoMetec's most important market, the North American market for cell and gene therapy, has been affected by three factors [...]
Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation
24/03/2026
IM8 90-Day Subscribers Unlock SuperPower Blood Testing for $49 — A 75% Saving on the Standard $199 Price. IM8 and Superpower create the first closed-loop system in consumer health – connecting clinical-grade [...]
Leo International Precision Health AG approves cash capital increase excluding subscription rights
24/03/2026
Leo International Precision Health AG / Keyword: Capital measures / Capital increase Leo International Precision Health AG approves cash capital increase excluding subscription rights 24. Mar 2026 / 17:44 CET/CEST [...]
IMUNON to Hold 2025 Financial Results and Business Update Conference Call on Tuesday, March 31, 2026
24/03/2026
LAWRENCEVILLE, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- IMUNON , Inc. (Nasdaq: IMNN) , a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that the Company will host a [...]

Pages